Biolinerx Unveils Q3 2025 Financials And Corporate Update
24 Nov 2025 //
PR NEWSWIRE
Hemispherian Secures GLIX1 Patent for Solid Tumors
19 Nov 2025 //
BUSINESSWIRE
Biolinerx, Hemispherian As Form Joint Venture For Glix1
29 Sep 2025 //
PR NEWSWIRE
Hemispherian Gets FDA IND Clearance for Glioblastoma Drug GLIX1
06 Aug 2025 //
PR NEWSWIRE
Hemispherian Gets FDA Orphan Drug Status for GLIX1
01 Jul 2025 //
PR NEWSWIRE
Hemispherian gets positive opinion for GLIX1 in glioma EU
06 Jun 2025 //
PR NEWSWIRE
Hemispherian raises tranche of a Series A to fund novel cancer therapeutics
24 Nov 2022 //
PRNEWSWIRE

Market Place
Sourcing Support